WilliamsRJTseTDiPiazzaK, et al. Terminated trials in the ClinicalTrials.gov results database: evaluation of availability of primary outcome data and reasons for termination. PLoS ONE2015; 10(5): e0127242.
2.
PahusLAlaghaKSofalviT, et al. External validity of randomized controlled trials in severe asthma. Am J Respir Crit Care Med2015; 192(2): 259–261.
3.
KerbratAFerreJCFillatreP, et al. Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase. N Engl J Med2016; 375(18): 1717–1725.
4.
BirdSMBaileyRAGrieveAP, et al. Statistical issues in first-in-human studies on BIA 10-2474: neglected comparison of protocol against practice. Pharm Stat2017; 16(2): 100–106.
5.
Funck-BrentanoCMénardJ.The BIAL/Biotrial case of death of a human volunteer in the first-in-human study of BIA 10-2474: are we missing the fundamentals?Presse Médicale2016; 45: 719–722.
6.
ChaikinP.The Bial10-2474 phase 1 study-A drug development perspective and recommendations for future first-in-human trials. J Clin Pharmacol2017: 57: 690–703.
7.
MooreN.Lessons from the fatal French study BIA-10-2474. BMJ2016; 353: i2727.
KaurRSidhuPSinghS.What failed BIA 10-2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials. J Pharmacol Pharmacother2016; 7(3): 120–126.
10.
ShaversVLLynchCFBurmeisterLF.Knowledge of the Tuskegee study and its impact on the willingness to participate in medical research studies. J Natl Med Assoc2000; 92(12): 563–572.
11.
BouidaWGrissaMHZorgatiA, et al. Willingness to participate in health research: Tunisian survey. BMC Med Ethics2016; 17(1): 47.
12.
GlassDCKelsallHLSlegersC, et al. A telephone survey of factors affecting willingness to participate in health research surveys. BMC Public Health2015; 15: 1017.
